Evidence map›Paper›PMID 27183611›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.

Sophie B Morgan, Johanneke D Hemmink, Emily Porter, Ross Harley, Holly Shelton, Mario Aramouni, Helen E Everett, Sharon M Brookes, Michael Bailey, Alain M Townsend and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Sophie B MorganThe Pirbright Institute, Surrey GU24 0NF, United Kingdom;
Johanneke D HemminkThe Pirbright Institute, Surrey GU24 0NF, United Kingdom;ORCID 0000-0001-8764-4156
Emily PorterSchool of Veterinary Sciences, University of Bristol, Bristol BS40 5DU, United Kingdom;ORCID 0000-0002-1213-3260
Ross HarleySchool of Veterinary Sciences, University of Bristol, Bristol BS40 5DU, United Kingdom;ORCID 0000-0001-9663-4486
Holly SheltonThe Pirbright Institute, Surrey GU24 0NF, United Kingdom;
Mario AramouniThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom;
Helen E EverettVirology Department, Animal and Plant Health Agency, Weybridge, Surrey KT15 3NB, United Kingdom; and.
Sharon M BrookesVirology Department, Animal and Plant Health Agency, Weybridge, Surrey KT15 3NB, United Kingdom; and.
Michael BaileySchool of Veterinary Sciences, University of Bristol, Bristol BS40 5DU, United Kingdom;
Alain M TownsendWeatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Bryan CharlestonThe Pirbright Institute, Surrey GU24 0NF, United Kingdom;
Elma TchilianThe Pirbright Institute, Surrey GU24 0NF, United Kingdom; elma.tchilian@pirbright.ac.uk.
The Pirbright Institute · GBUniversity of Bristol · GBAnimal and Plant Health Agency · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L001330/1
6 · The paper itself

Abstract

Influenza A viruses are a major health threat to livestock and humans, causing considerable mortality, morbidity, and economic loss. Current inactivated influenza vaccines are strain specific and new vaccines need to be produced at frequent intervals to combat newly arising influenza virus strains, so that a universal vaccine is highly desirable. We show that pandemic H1N1 influenza virus in which the hemagglutinin signal sequence has been suppressed (S-FLU), when administered to pigs by aerosol can induce CD4 and CD8 T cell immune responses in blood, bronchoalveolar lavage (BAL), and tracheobronchial lymph nodes. Neutralizing Ab was not produced. Detection of a BAL response correlated with a reduction in viral titer in nasal swabs and lungs, following challenge with H1N1 pandemic virus. Intratracheal immunization with a higher dose of a heterologous H5N1 S-FLU vaccine induced weaker BAL and stronger tracheobronchial lymph node responses and a lesser reduction in viral titer. We conclude that local cellular immune responses are important for protection against influenza A virus infection, that these can be most efficiently induced by aerosol immunization targeting the lower respiratory tract, and that S-FLU is a promising universal influenza vaccine candidate.

Indexed as

Viral LoadAerosolsAnimalsAntibodies, NeutralizingCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHemagglutinin Glycoproteins, Influenza VirusHumansImmunity, CellularInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeInfluenza, HumanInfluenza VaccinesInterferon-gammaLungNoseAerosolsAntibodies, NeutralizingHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesInterferon-gammaVaccines, Inactivated

Identifiers

PMID27183611
PMCPMC4891568
OpenAlexW2346826388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.